Advertisement

Topical application of autologous adipose-derived mesenchymal stem cells (MSCs) for persistent sterile corneal epithelial defect

  • George I. Agorogiannis
  • Vassilia-Ismini Alexaki
  • Ourania Castana
  • George D. Kymionis
Case Report

Introduction

Different causes of corneal persistent epithelial defects (PED) have been described including dry eye, corneal epithelial stem cell deficiency, diabetes mellitus, and neurotrophic keratopathy (after herpetic keratitis or corneal surgery). Corneal PEDs could lead to a cascade of events throughout the cornea, resulting in stromal degradation, thinning and in advanced cases, corneal perforation.

Several treatment options have been proposed for corneal PEDs (based on the etiology) such as eye patching, unpreserved artificial tears, bandage contact lens, punctual plugging, tarsorrhaphy, autologous serum eyedrops, limbal stem cells transplantation, and amniotic membrane grafting.

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types. Clinical uses of these cells have been proposed, such as in patients with degenerative joint disease (using percutaneously implanted autologous MSCs) [1], while adipose-derived MSCs have been...

Keywords

Central Corneal Thickness Keratoconus Corrected Distance Visual Acuity Corneal Perforation Corneal Epithelial Defect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

We thank the heads of the Ophthalmology and Experimental Endocrinology departments (University of Crete, School of Medicine, Heraklion, Greece), Professors Ioannis G Pallikaris and Elias Castanas, for their constant support and fruitful discussions, which stimulated the current study.

References

  1. 1.
    Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D (2008) Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician 11:343–353PubMedGoogle Scholar
  2. 2.
    Arnalich-Montiel F, Pastor S, Blazquez-Martinez A, Fernandez-Delgado J, Nistal M, Alio JL (2008) Adipose-derived stem cells are a source for cell therapy of the corneal stroma. Stem Cells 26:570–579PubMedCrossRefGoogle Scholar
  3. 3.
    Bunnell BA, Flaat M, Gaqliardi C, Patel B, Ripoll C (2008) Adipose-derived stem cells: isolation, expansion and differentiation. Methods 45:115–120PubMedCrossRefGoogle Scholar
  4. 4.
    Alexaki VI, Notas G, Pelekanou V, Kampa M, Valkanou M, Theodoropoulos P, Stathopoulos EN, Tsapis A, Castanas E (2009) Adipocytes as immune cells: differential expression of TWEAK, BAFF and APRIL and their receptors (Fn14, BAFF-R, TACI and BCMA) at different stages of normal and pathological adipose tissue development. J Immunol 183:5948–5956PubMedCrossRefGoogle Scholar
  5. 5.
    Daher SR, Johnstone BH, Phinney DG, March KL (2008) Adipose stromal/stem cells: basic and translational advances: the IFATS collection. Stem Cells 26:2664–2665PubMedCrossRefGoogle Scholar
  6. 6.
    Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726–736PubMedCrossRefGoogle Scholar
  7. 7.
    Phinney DG, Prockop DJ (2007) Mesenchymal stem/multi-potent stromal cells (MSCs): the state of transdifferentiation and modes of tissue repair — current views. Stem Cells 25:2896–2902PubMedCrossRefGoogle Scholar
  8. 8.
    Körbling M, Estrov Z (2003) Adult stem cells for tissue repair — a new therapeutic concept? N Engl J Med 349:570–582PubMedCrossRefGoogle Scholar
  9. 9.
    Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M (2001) Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344:385–386PubMedCrossRefGoogle Scholar
  10. 10.
    Meirelles Lda S, Fontes AM, Covas DT, Caplan AI (2009) Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20:419–427PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • George I. Agorogiannis
    • 1
  • Vassilia-Ismini Alexaki
    • 2
  • Ourania Castana
    • 3
  • George D. Kymionis
    • 1
    • 4
  1. 1.Eye ClinicUniversity Hospital of Heraklion, CreteHeraklionGreece
  2. 2.Laboratory of Experimental EndocrinologyUniversity of Crete, School of MedicineHeraklionGreece
  3. 3.Department of Plastic and Reconstructive SurgeryEvangelismos General HospitalAthensGreece
  4. 4.University of Crete, School of Medicine, Department of OphthalmologyUniversity Hospital of CreteHeraklionGreece

Personalised recommendations